Skip to main content
×
×
Home

Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England

  • M. A. BALOGUN (a1), J. V. PARRY (a2) (a3), K. MUTTON (a4), C. OKOLO (a5), L. BENONS (a5), H. BAXENDALE (a6), T. HARDIMAN (a6), E. H. BOXALL (a7) (a8), J. SIRA (a8), M. BROWN (a8), S. BARNETT (a2), U. GUNGABISSOON (a1), A. WILLIAMS (a9), D. A. KELLY (a8), S. VIJERATNAM (a10), S. IJAZ (a2), B. TAYLOR (a6), C. G. TEO (a2) and M. E. RAMSAY (a1)...
Summary
SUMMARY

The aim of this study was to estimate the amount of childhood hepatitis B virus transmission in children born in the UK, a very low-prevalence country, that is preventable only by universal hepatitis B immunization of infants. Oral fluid specimens were collected from schoolchildren aged 7–11 years in four inner city multi-ethnic areas and tested for the presence of antibody to hepatitis B core antigen (anti-HBc). Those found positive or indeterminate were followed up with testing on serum to confirm their hepatitis B status. The overall prevalence of anti-HBc in children was low [0·26%, 95% confidence interval (CI) 0·14–0·44]. The estimated average annual incidence of hepatitis B was estimated to be 29·26/100 000 children (95% CI 16·00–49·08). The total incidence that is preventable only by a universal infant immunization programme in the UK was estimated to be between 5·00 and 12·49/100 000. The study demonstrates that the extent of horizontal childhood hepatitis B virus transmission is low in children born in the UK and suggests that schools in the UK are an uncommon setting for the transmission of the virus. Targeted hepatitis B testing and immunization of migrants from intermediate- and high-prevalence countries is likely to be a more effective measure to reduce childhood transmission than a universal infant immunization programme.

Copyright
Corresponding author
*Author for correspondence: Dr M. A. Balogun, Health Protection Agency, Immunisation, Hepatitis and Blood Safety Department, 61 Colindale Avenue, London NW9 5EQ, UK. (Email: koye.balogun@hpa.org.uk)
References
Hide All
1.Ahn S H, et al. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions. Hepatology International 2010; 4: 386395.
2.Plymoth A, Viviani S, Hainaut P. Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention. Cancer Letters 2009; 286: 1521.
3.Fung J, Lai CL, Yuen MF. Hepatitis B and C virus-related carcinogenesis. Clinical Microbiology and Infection 2009; 15: 964970.
4.Kao JH, et al. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. Journal of Pediatrics 2001; 139: 349352.
5.Montesano R. Hepatitis B immunization and hepatocellular carcinoma; The Gambia Hepatitis Intervention Study. Journal of Medical Virology 2002; 67: 444446.
6.Chang MH, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20 year follow-up. Journal of the National Cancer Institute 2009; 101: 13481355.
7.Brook MG, et al. Antenatal screening for hepatitis B is medically and economically effective in the prevention and vertical transmission: three years experience in a London. Quarterly Journal of Medicine 1989; 71: 313317.
8.Dwyer MJ, McIntyre PG. Antenatal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area. Epidemiology and Infection 1996; 117: 121131.
9.Jordan R, Law M. An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B. Journal of Medical Screening 1997; 4: 117127.
10.Balogun MA, et al. Acute hepatitis B infection in England and Wales: 1985–1996. Epidemiology and Infection 1999; 122: 125133.
11.Hahné S. et al. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy. Journal of Clinical Virology 2004; 29: 211220.
12.Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B infection to United States born children of Hmong refugees. Pediatrics 1992; 89: 269273.
13.Diel R, Helle J, Gottschalk R. Transmission of hepatitis B in Hamburg, Germany, 1998–2002 a perspective population based study. Medical Microbiology and Immunology 2005; 194: 193199.
14.Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989; 1: 889893.
15.Martinson FE, et al. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. American Journal of Epidemiology 1998; 147: 478487.
16.Doganci T, et al. Horizontal transmission of hepatitis B virus in children with chronic hepatitis B. The World Journal of Gastroenterology 2005; 11: 418420.
17.Hahné S, et al. Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy. Archives of Disease in Childhood 2003; 88: 10821083.
18.Değertekin H, Tuzcu A, Yalçin K. Horizontal transmission of HBV infection among students in Turkey. Public Health 2000; 114: 411412.
19.Mckie A, Vyse A, Maple C. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infectious Diseases 2002; 2: 1824.
20.Vyse AJ, Cohen BJ, Ramsay ME. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 2001; 115: 201207.
21.Chatzipantazi P, et al. The feasibility and acceptability of collecting oral fluid from healthy children for anti-HCV testing. Archives of Disease in Childhood 2004; 89: 185187.
22.Parry JV, et al. Diagnosis of hepatitis A and B by testing saliva. Journal of Medical Virology 1989; 28: 255260.
23.Parry J. Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance. Annals of the New York Academy of Sciences 1993; 694: 216233.
24.Thornton L, et al. Comparison between self-reported hepatitis B, hepatitis C, and HIV antibody status and oral fluid assay results in Irish prisoners. Communicable Disease and Public Health 2000; 3: 253255.
25.Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 1987; 2: 7275.
26.Yusof JH, Flower AJ, Teo CG. Transmission of hepatitis B virus analyzed by conformation-dependent polymorphisms of single-stranded viral DNA. Journal of Infectious Diseases 1994; 169: 6267.
27.Hesketh LM, et al. Childhood infection with hepatitis A and B viruses in England and Wales. Communicable Disease Report 1997; 7: R60R63.
28.Franks AL, et al. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. New England Journal of Medicine 1989; 321: 13011305.
29.Mahoney FJ, et al. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. Pediatrics 1995; 96: 11131116.
30.Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 1996; 38: S39S42.
31.Hsu SC, et al. Horizontal transmission of hepatitis B virus in children. Journal of Pediatric Gastroenterology and Nutrition 1993; 16: 6669.
32.Martinson FE, et al. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. American Journal of Epidemiology 1998; 147: 478487.
33.Kawsar M, Goh BT. Hepatitis B virus infection among Chinese residents in the United Kingdom. Sexually Transmitted Infections 2002; 78: 166168.
34.Aweis D, et al. Hepatitis B prevalence and risk factors for HBsAg carriage amongst Somali households in Liverpool. Communicable Disease and Public Health 2001; 4: 247252.
35.Gjørup IE, et al. Changing epidemiology of HBV infection in Danish children. Journal of Infection 2003; 47: 231235.
36.Fisker N, et al. Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centres. Journal of Medical Virology 2002; 68: 500504.
37.Burgess MA, et al. Hepatitis B in urban Australian schoolchildren. No evidence of horizontal transmission between high-risk and low risk groups. Medical Journal of Australia 1993; 159: 315319.
38.Repp R, et al. Risk of hepatitis B transmission in school. Lancet 1994; 344: 961962.
39.Hayashi J, et al. Hepatitis B virus transmission in nursery schools. American Journal of Epidemiology 1987; 125: 492498.
40.Goldstein ST, et al. Incidence and risk factors for acute heparitis B in the United States 1982–1998 implications for vaccination program. Journal of Infectious Diseases 2002; 185: 713719.
41.Ramsay M, et al. Control of hepatitis B in the United Kingdom. Vaccine 1998; 16 (Suppl.) S52S55.
42.Lindh M, et al. Hepatitis B carriers in Sweden: effects of immigration. Scandinavian Journal of Infectious Diseases 1993; 25: 411416.
43.Veldhuijzen IK, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection Is cost-effective. Gastroenterology 2010; 138: 522530.
44.Tilson L, et al. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation. European Journal of Public Health 2007; 18: 275282.
45.Edmunds WJ. Universal or selective immunisation againsthepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies. Communicable Disease and Public Health 1998; 1: 221228.
46.Etuwewe O, Wood A, Lyon A. Delivering a selective neonatal BCG vaccination programme in a multi-ethnic community: an audit of the neonatal BCG immunisation programme in Birmingham and Solihull. Communicable Disease and Public Health 2004; 7: 172176.
47.Galama JM. National hepatitis B vaccination closer to implementation but not soon enough: recommendation s from the Dutch Health Council. Nederlands Tijdschrift voor Geneeskunde 2001; 145: 13391342.
48.Gay NJ, Edmunds WJ. Developed countries could pay for hepatitis B vaccination in developing countries. British Medical Journal 1998; 316: 1457.
49.Larcher VF, et al. Overcoming barriers to hepatitis B immunisation by a dedicated hepatitis B immunisation service. Archives of Disease in Childhood 2001; 84: 114119.
50.Giraudon I, et al. Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006. Vaccine 2009; 27: 20162022.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 1
Total number of PDF views: 21 *
Loading metrics...

Abstract views

Total abstract views: 172 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 25th February 2018. This data will be updated every 24 hours.